News and Trends 11 Jul 2022
Financing round of $21M completed for drug to treat autoimmune diseases
The first-round of financing to the tune of $21 million (€20.6 million), for a drug to treat autoimmune disease, has been completed between Precision Autoimmune Therapeutics (PAT) and CASI Pharmaceuticals.…